MET.EXTRA GROUP SPA (MET.MI) Fundamental Analysis & Valuation

BIT:MET • IT0005481855

Current stock price

1.83 EUR
-0.17 (-8.5%)
Last:

This MET.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MET.MI Profitability Analysis

1.1 Basic Checks

  • In the past year MET was profitable.
  • MET had a positive operating cash flow in the past year.
  • MET had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: MET reported negative operating cash flow in multiple years.
MET.MI Yearly Net Income VS EBIT VS OCF VS FCFMET.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

  • With an excellent Return On Assets value of 5.90%, MET belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
  • MET has a better Return On Equity (9.26%) than 61.40% of its industry peers.
  • The Return On Invested Capital of MET (9.82%) is better than 77.19% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MET is in line with the industry average of 10.69%.
Industry RankSector Rank
ROA 5.9%
ROE 9.26%
ROIC 9.82%
ROA(3y)6.31%
ROA(5y)2.56%
ROE(3y)9.8%
ROE(5y)1.51%
ROIC(3y)10.32%
ROIC(5y)N/A
MET.MI Yearly ROA, ROE, ROICMET.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • The Profit Margin of MET (5.75%) is comparable to the rest of the industry.
  • The Operating Margin of MET (10.30%) is comparable to the rest of the industry.
  • Looking at the Gross Margin, with a value of 16.59%, MET is doing worse than 63.16% of the companies in the same industry.
  • MET's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.3%
PM (TTM) 5.75%
GM 16.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.46%
GM growth 5YN/A
MET.MI Yearly Profit, Operating, Gross MarginsMET.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MET.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MET is still creating some value.
  • Compared to 1 year ago, MET has about the same amount of shares outstanding.
  • The number of shares outstanding for MET has been reduced compared to 5 years ago.
  • Compared to 1 year ago, MET has an improved debt to assets ratio.
MET.MI Yearly Shares OutstandingMET.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MET.MI Yearly Total Debt VS Total AssetsMET.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of 1.57, we must say that MET is in the distress zone and has some risk of bankruptcy.
  • MET's Altman-Z score of 1.57 is in line compared to the rest of the industry. MET outperforms 57.89% of its industry peers.
  • MET has a debt to FCF ratio of 72.26. This is a negative value and a sign of low solvency as MET would need 72.26 years to pay back of all of its debts.
  • MET has a Debt to FCF ratio of 72.26. This is in the lower half of the industry: MET underperforms 64.91% of its industry peers.
  • MET has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
  • MET has a better Debt to Equity ratio (0.15) than 75.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 72.26
Altman-Z 1.57
ROIC/WACC1.7
WACC5.77%
MET.MI Yearly LT Debt VS Equity VS FCFMET.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 1.87 indicates that MET should not have too much problems paying its short term obligations.
  • MET's Current ratio of 1.87 is fine compared to the rest of the industry. MET outperforms 71.93% of its industry peers.
  • MET has a Quick Ratio of 1.48. This is a normal value and indicates that MET is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MET (1.48) is better than 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.48
MET.MI Yearly Current Assets VS Current LiabilitesMET.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MET.MI Growth Analysis

3.1 Past

  • MET shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.44%, which is quite impressive.
  • The Revenue has grown by 30.81% in the past year. This is a very strong growth!
  • Measured over the past years, MET shows a very strong growth in Revenue. The Revenue has been growing by 126.36% on average per year.
EPS 1Y (TTM)46.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.48%
Revenue 1Y (TTM)30.81%
Revenue growth 3Y297.58%
Revenue growth 5Y126.36%
Sales Q2Q%49.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MET.MI Yearly Revenue VS EstimatesMET.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

Find the best growth stocksShow best growing peers

4

4. MET.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.61, the valuation of MET can be described as very cheap.
  • MET's Price/Earnings ratio is rather cheap when compared to the industry. MET is cheaper than 91.23% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.87. MET is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.61
Fwd PE N/A
MET.MI Price Earnings VS Forward Price EarningsMET.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • MET's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MET is cheaper than 84.21% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MET indicates a somewhat cheap valuation: MET is cheaper than 73.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.77
EV/EBITDA 1.23
MET.MI Per share dataMET.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MET.MI Dividend Analysis

5.1 Amount

  • No dividends for MET!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MET.MI Fundamentals: All Metrics, Ratios and Statistics

MET.EXTRA GROUP SPA

BIT:MET (4/7/2026, 7:00:00 PM)

1.83

-0.17 (-8.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.06M
Revenue(TTM)50.98M
Net Income(TTM)2.93M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.61
Fwd PE N/A
P/S 0.02
P/FCF 8.77
P/OCF 0.23
P/B 0.03
P/tB 0.07
EV/EBITDA 1.23
EPS(TTM)0.7
EY38.25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY11.4%
OCF(TTM)8.06
OCFY440.64%
SpS87.9
BVpS54.58
TBVpS27.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number29.3203 (1502.2%)
Profitability
Industry RankSector Rank
ROA 5.9%
ROE 9.26%
ROCE 14.24%
ROIC 9.82%
ROICexc 10.31%
ROICexgc 18.81%
OM 10.3%
PM (TTM) 5.75%
GM 16.59%
FCFM 0.24%
ROA(3y)6.31%
ROA(5y)2.56%
ROE(3y)9.8%
ROE(5y)1.51%
ROIC(3y)10.32%
ROIC(5y)N/A
ROICexc(3y)10.81%
ROICexc(5y)N/A
ROICexgc(3y)24.44%
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 72.26
Debt/EBITDA 0.72
Cap/Depr 354.55%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 71.55%
Profit Quality 4.13%
Current Ratio 1.87
Quick Ratio 1.48
Altman-Z 1.57
F-Score6
WACC5.77%
ROIC/WACC1.7
Cap/Depr(3y)150.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.95%
Cap/Sales(5y)2.42%
Profit Quality(3y)203.21%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.81%
Revenue growth 3Y297.58%
Revenue growth 5Y126.36%
Sales Q2Q%49.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.94%
OCF growth 3YN/A
OCF growth 5YN/A

MET.EXTRA GROUP SPA / MET.MI Fundamental Analysis FAQ

What is the fundamental rating for MET stock?

ChartMill assigns a fundamental rating of 4 / 10 to MET.MI.


Can you provide the valuation status for MET.EXTRA GROUP SPA?

ChartMill assigns a valuation rating of 4 / 10 to MET.EXTRA GROUP SPA (MET.MI). This can be considered as Fairly Valued.


How profitable is MET.EXTRA GROUP SPA (MET.MI) stock?

MET.EXTRA GROUP SPA (MET.MI) has a profitability rating of 4 / 10.